Literature DB >> 11580852

Polymorphism of the human retinoid X receptor beta and linkage disequilibrium with HLA-DPB1.

R Rajsbaum1, D Fici, P A Fraser, P O Flores-Villanueva, Z L Awdeh.   

Abstract

The human retinoid X receptor beta (RXRB) gene is localized in the major histocompatibility complex (MHC) region between DPB1 and RING2. The RXRB gene sequence reported by different investigators suggests that the gene may be polymorphic. In this study, we confirmed one polymorphism by sequencing genomic DNA from four Caucasian individuals. We also developed a restriction fragment length polymorphism (RFLP) analysis to detect this specific polymorphism. Linkage analysis studies between RXRB alleles and a number of HLA markers showed significant linkage disequilibrium between RXRB*T and HLA-DPB1*0401.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580852     DOI: 10.1034/j.1399-0039.2001.580104.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Profiling of differentially expressed genes in sheep T lymphocytes response to an artificial primary Haemonchus contortus infection.

Authors:  Yi Yang; Qian-Jin Zhou; Xue-Qiu Chen; Bao-Long Yan; Xiao-Lu Guo; Hong-Li Zhang; Ai-Fang Du
Journal:  Parasit Vectors       Date:  2015-04-18       Impact factor: 3.876

2.  On the Wegener granulomatosis associated region on chromosome 6p21.3.

Authors:  Paweł Szyld; Peter Jagiello; Elena Csernok; Wolfgang L Gross; Joerg T Epplen
Journal:  BMC Med Genet       Date:  2006-03-09       Impact factor: 2.103

3.  Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China.

Authors:  Shih-Chen Chang; Asif Rashid; Yu-Tang Gao; Gabriella Andreotti; Ming-Chang Shen; Bin-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Lori C Sakoda; Michael F Leitzmann; Bingshu E Chen; Philip S Rosenberg; Jinbo Chen; Stephen J Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2008-03-28       Impact factor: 4.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.